Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Dohányzási zavar
Total 0 results
Nothing found
Sponsors and Collaborators
Reina Sofia University Hospital
Yantai Yuhuangding Hospital,Medical College, Qingdao University
Veeda Oncology
Bjørgene Omsorgssenter, Haugesund
Nestor Soler Porcar, MD, PhD
Maria Lendorf
Equipe MiMes
AIDS Council of New South Wales
Chengdu Nuoen Biotechnologies, Inc.
InflaRx GmbH
Neuregenix
Mononuclear Therapeutics Ltd.
Prestige Biopharma Limited
Centro di Procreazione Assistita Demetra
Women and children's hospital of Jiaxing university
BayCare Health System
Grand Challenges Canada
Bruce County Paramedic Service
North Karelia Hospital District
ImproveCareNow (ICN)
View Full List
Medical Conditions
Cutaneous Leiomyomata With Uterine Leiomyomata
Tay-Sachs Disease Ganglioside
Closure; Foramen Ovale
Fetus or Neonate Affected by External Version Before Labor
Painless Hysteroscopy
Fracture Dislocation of Cervical Spine
Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
Psoriasis, Arthritic
Endocarditis Infective
Epidemic Hemorrhagic Fever
Pulmonary Adenocarcinoma
Spine Surgeries
Ewing's Family Tumors
Skull Base Neoplasms
Chlamydophila Infections
Gullian Barre Syndrome
Predictors of Atrial Fibrillation Recurrences
Childhood Langerhans Cell Histiocytosis
Multisystem Proteinopathy
View Full List
Drug Interventions
Glimepiride
Semapimod
Cereport
Redifferentiation with retinoid acid
Mocetinostat - Recommended Phase 2 Dose (70 mg)
Vehicle
PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
Azelastine hydrochloride (BAYR9258)
Adapalene Gel 0.3%
Estradiol+Drospirenone
Chemotherapeutic Agent
Qingkailing injection 40 ml
Naltrexone 50 mg/day + Cognitive Behavioral Therapy
Palliative care group first-line scheme
Esomeprazole 40mg before
EFV +TVA
Neihulizumab
NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
High dose pantoprazole infusion
Adriamycin
View Full List
CROs by country
Contract Research Organizations in Bahrain
Contract Research Organizations in Canada
Contract Research Organizations in Macedonia
Contract Research Organizations in Malawi
Contract Research Organizations in Pakistan
Contract Research Organizations in Panama
Contract Research Organizations in Russia
Contract Research Organizations in Tanzania
Contract Research Organizations in Thailand
Contract Research Organizations in Togo
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Venezuela
Contract Research Organizations in Vietnam
CRO list by country
CROs in Suriname
SGS
All CROs in Suriname
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe